Valuation: Dr. Reddy's Laboratories Limited

Capitalization 1,049B 12.2B 10.51B 9.78B 9.11B 16.75B 18.73B 118B 44.82B 491B 45.77B 44.83B 1,817B P/E ratio 2026 *
18.1x
P/E ratio 2027 * 21.7x
Enterprise value 1,005B 11.69B 10.07B 9.37B 8.73B 16.04B 17.94B 114B 42.93B 470B 43.84B 42.94B 1,740B EV / Sales 2026 *
2.85x
EV / Sales 2027 * 2.79x
Free-Float
70.34%
Yield 2026 *
0.81%
Yield 2027 * 0.85%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.82%
1 week-1.77%
Current month-1.76%
1 month-7.37%
3 months+9.11%
6 months-5.83%
Current year-9.16%
More quotes
1 week 1,241.4
Extreme 1241.4
1,272.1
1 month 1,212.35
Extreme 1212.35
1,353
Current year 1,025.9
Extreme 1025.9
1,404.6
1 year 1,025.9
Extreme 1025.9
1,420.2
3 years 799.22
Extreme 799.22
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 2019-06-30
Chief Tech/Sci/R&D Officer - 2023-07-31
Compliance Officer - 2022-03-16
Director TitleAgeSince
Chairman 57 2014-05-12
Chairman 64 2013-04-01
Director/Board Member 64 2018-10-24
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.82%-1.77%-7.17%+38.81% 12.1B
-3.45%-0.76%-18.80%+132.74% 718B
-1.05%-0.40%+3.97%-12.94% 377B
-1.84%-1.78%+10.93%+21.33% 338B
-2.29%-3.74%-55.50%+3.48% 308B
-1.05%-1.05%-1.43%-23.16% 259B
-0.38%-1.69%-3.07%+16.27% 237B
-1.56%+1.51%-13.28%-5.53% 222B
-2.57%+0.18%-36.37%-14.15% 210B
-1.52%-1.51%-11.40%+17.62% 160B
Average -0.74%-0.35%-13.21%+17.45% 284.21B
Weighted average by Cap. -0.75%-0.11%-13.72%+33.63%
See all sector performances

Financials

2026 *2027 *
Net sales 353B 4.11B 3.54B 3.29B 3.07B 5.64B 6.3B 39.88B 15.08B 165B 15.4B 15.09B 612B 351B 4.08B 3.51B 3.27B 3.04B 5.59B 6.26B 39.58B 14.97B 164B 15.29B 14.97B 607B
Net income 58.44B 680M 585M 545M 507M 933M 1.04B 6.6B 2.5B 27.34B 2.55B 2.5B 101B 48.64B 566M 487M 453M 422M 776M 868M 5.49B 2.08B 22.75B 2.12B 2.08B 84.21B
Net Debt -44.24B -514M -443M -412M -384M -706M -790M -5B -1.89B -20.69B -1.93B -1.89B -76.59B -70.73B -823M -708M -659M -614M -1.13B -1.26B -7.99B -3.02B -33.09B -3.09B -3.02B -122B
More financial data * Estimated data
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,811
More about the company
Date Price Change Volume
25-07-15 1,261.15 +0.82% 13,083
25-07-14 1,250.95 -0.24% 10,372
25-07-11 1,254.00 -0.41% 214,602
25-07-10 1,259.20 -0.82% 51,480
25-07-09 1,269.55 -1.12% 74,082

Delayed Quote Bombay S.E., July 15, 2025 at 06:00 am EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,261.15INR
Average target price
1,262.39INR
Spread / Average Target
+0.10%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DRREDDY Stock